In the News

Updates

We are pleased to announce that TechInvention has been selected in the alpha category for the Immersion-Collision Conference 2022 being held at the Enercare Centre, Toronto, Canada, on the 16th of June 2022 to the 25th June 2022. See the post on LinkedIn.

The Indian Economic Trade Organization (IETO) invited our CEO, Syed S Ahmed, to speak on vaccine collaborations on the occasion of the India-Cuba Trade Conference on March 18th,2022.

TechInvention is now a Department of Biotechnology’s BIRAC Biotechnology Ignition Grant (BIG) – 19 Awardee

Synopsis: It gives us great pleasure to inform you that we have been awarded the Biotechnology Ignition Grant 19 Scheme by DBT BIRAC for our project titled “Development of Recombinant Lysins Against Drug-Resistant E.coli”.

The speedy growth of antimicrobial resistance (AMR), which is one of the biggest threats to global health, the economy, and development today, calls for immediate action. It has never been of more importance to realise the gravity of the situation and work towards preparedness in order to face the raging issue that is on the brink of becoming a pandemic.

That’s why we at TechInvention are striving to make a difference with a platform technology that can enable the introduction of enzybiotics against pathogens listed under the critical category of the World Health Organization for AMR.

TechInvention awarded the ‘India SME Excellence Award’ – Healthcare Sector

Synopsis: SME Chamber of India has presented the 21st Edition of “INDIA SME EXCELLENCE AWARDS” to TechInvention Lifecare Pvt. Ltd., as a SME of the Year Award in the Healthcare Sector. The Award was received by Mr. Syed S Ahmed – Director & CEO, TechInvention Lifecare Pvt. Ltd., and presented by Hon’ble Governor of Maharashtra, Shri Bhagat Singh Koshyari on 13th February 2022 at the Raj Bhavan, Mumbai.

In the news

Techinvention was amongst the few startups from 61,000 startups to be selected to make policy recommendations to the prime minister under the Theme ‘Nudging the DNA’ as of an initiative by DPIIT, startup India, and Invest India in accordance with the startup innovation week that was celebrated from 10th to 16th January under the grand celebration of Azadi ka Amrit Mahotsav.
See the post on LinkedIn.

Positive outcomes for Techinvention’s indigenously developed recombinant subunit SARS-CoV-2 vaccine is the news of the moment! Read the story in Financial Express or download the press release.

TechInvention’s collaboration with Eubiologics, South Korea, to bring the world’s first and only oral cholera vaccine in a LDPE unidose pack to India made the headlines!
Read the coverage in Express Pharma, ET Healthworld, MedIndia, Outlook Magazine and Yahoo Finance.

We were recently featured in Saif Talk magazine.
Read the article here (PDF).

SwiftNLift Magazine counted us among the top 10 Best Biotechnology Companies of 2020.
Read the interview with our founder (PDF).

Business Sight Magazine includes our founder in their Elite League of Innovative Entrepreneurs for 2020.
Read the profile.

Techinvention is honoured to join the fight against Covid-19. We’re funding BioNest-PU’s research into the diagnosis and prophylaxis of the novel SARS-CoV2.
Read the article.

Startup City Magazine interviewed our founder Syed S Ahmed for their Best Company Of The Year 2019 series.
Read the interview (PDF).

Insights Care Magazine says we’re one of the most innovative biotech companies to watch in 2019.
Read the interview with our founder.

We’re honoured to be chosen by Silicon India – Healthcare as one of the 10 most promising Biotechnology companies of 2019.
Read the article.

Recognition

Close Menu

We are pleased to announce that TechInvention has been selected in the alpha category for the Immersion-Collision Conference 2022 being held at the Enercare Centre, Toronto, Canada, on the 16th of June 2022 to the 25th June 2022.